基础医学与临床 ›› 2022, Vol. 42 ›› Issue (5): 763-767.doi: 10.16352/j.issn.1001-6325.2022.05.018

• 研究论文 • 上一篇    下一篇

昆虫细胞表达的HPV-58 L1病毒样颗粒的层析纯化及免疫原性分析

王志荣, 张婷, 许雪梅*   

  1. 中国医学科学院基础医学研究所 北京协和医学院基础学院 生物物理及结构生物学系,北京 100005
  • 收稿日期:2022-02-17 修回日期:2022-03-22 出版日期:2022-05-05 发布日期:2022-04-28
  • 通讯作者: * xuemeixu@vip.sina.com
  • 基金资助:
    国家自然科学基金(31970867);中国医学科学院医学与健康科技创新工程项目(2021-I2M-1-043)

Chromatography and immunogenicity analysis of HPV-58 L1 virus-like particles expressed from insect cells

WANG Zhi-rong, ZHANG Ting, XU Xue-mei*   

  1. Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences CAMS, School of Basic Medicine PUMC, Beijing 100005, China
  • Received:2022-02-17 Revised:2022-03-22 Online:2022-05-05 Published:2022-04-28
  • Contact: * xuemeixu@vip.sina.com

摘要: 目的 探索利用昆虫杆状病毒表达系统(IBEVS)表达的重组人乳头瘤病毒(HPV)58型主要衣壳蛋白L1病毒样颗粒(VLP)的简单可行的层析分离方法。方法 收集高水平表达HPV-58 L1的昆虫细胞并制备裂解上清,建立硫酸铵沉淀(ASP)联合层析法纯化L1蛋白的最佳条件,对纯化后的蛋白进行体外组装。对L1蛋白的纯化各个阶段中的组分、最终产品(纯品蛋白)及组装状态进行理化性质鉴定,分析其免疫原性。结果 30%饱和硫酸铵(AS)分级分离后,L1蛋白得率为72%,纯度为9.34%;阴离子交换层析经300 mmol/L NaCl缓冲液洗脱后,L1蛋白得率>90%,纯度为13.6%;进一步经羟基磷灰石层析收获流穿液后,L1蛋白得率>80%,宿主蛋白质残留(HCPs)分析和L1蛋白的SDS-PAGE考马斯亮蓝染色显示蛋白纯度>99 %。经上述3步分离纯化的L1蛋白,其总得率为55.7%,每升细胞悬浮培养液(约3.0×109个细胞)产量为57~65 mg。动态光散射(DLS)和透射电镜(TEM)分析显示,L1蛋白组装成了形状均一、直径约55 nm的VLPs。该法制备HPV-58 L1 VLPs诱导小鼠免疫系统产生的中和抗体水平与超离法制备的相当。结论 本研究所建立的HPV58-L1 VLPs分离纯化方法是一套具有蛋白得率高、活性好,且操作简单等特点的成熟方案,为利用IBEVS生产成本低的HPV多价预防性疫苗奠定基础。

关键词: 人乳头瘤病毒58型, 主要衣壳蛋白L1, 病毒样颗粒(VLP), 昆虫细胞, 纯化

Abstract: Objective To develop a simple chromatography purification process of human papillomavirus (HPV) type 58 L1 virus-like particle (VLP) produced by insect cells baculovirus expression vector system (IBEVS). Methods A previously constructed mutant of HPV-58 L1 with a high expression level in insect baculovirus system were used to prepare the cell lysates.The L1 containing sample was used for the establishment of optimal protein purification process which consisting of an initial process of ammonium sulfate precipitation (ASP) and two polishing chromatography purifications. Purified L1 protein was dialyzed for VLP reassembly and the resultant VLPs were characterized physicochemically and their immunogenicity was then analyzed in mice. Results L1 protein was purified by 30% ASP with good purity (9.34%) and recovery (72%). When bound to anion exchange resin and eluted by 300 mmol/L NaCl-contained buffer, the L1 protein was further purified with >90% of recovery and 13.6% of purity. The resultant L1 protein mainly flowed through the ceramic hydroxyapatite column with a recovery of >80% and purity was over 99.1% by HCP analysis. With the three-step purification, the total recovery of L1 was about 55.7% and the yield was 57-65 mg/L. Purified L1 proteins self-assembled into homogenous VLPs with an average diameter of 55 nm as proved by TEM and DLS, and these VLPs induced high titer of neutralizing antibodies, comparable to that of VLPs purified by ultracentrifugation. Conclusions The chromatography process for producing HPV-58 L1 VLPs showed good purity, yield, and immunogenicity and is believed to be a time-saving, easy-performing, fully scalable, and low-cost method. It may be used to produce low-cost and multivalent HPV VLP vaccine by IBEVS.

Key words: human papillomavirus type 58, major capsid protein L1, virus-like particle(VLP), insect cell, purification

中图分类号: